The percentage of patients with high TIM‐3 expression in colorectal, breast, and ovarian cancers was not significantly different from those in non‐colorectal, non‐breast, and non‐ovarian cancers, respectively (Table 2, Figure 2). The gene discussed is HAVCR2; the disease is ovarian carcinoma.